Validation of the multiple sclerosis neuropsychological screening questionnaire in Argentina

Multiple Sclerosis

Volumn 15, Issue 2, 2009, Pages 244-250

  Vanotti, S ^a   Benedict, R H B ^b,c   Acion, L ^d   Caceres F ^a   Barboza, A ^e   Bendersky, A ^e   Bestoso, S ^e   Casas Parera, I ^e   Garcea, O ^e   Fernandez Liguori N ^e   Gonorazky, S ^e   Labal, P ^e   Nunez V ^e   Pelli Noble, F ^e   Piedrabuena, R ^e   Rey, R ^e   Roca, A ^e   Rodriguez L ^e   Rudy, T ^e   Saladino, M ^e   Salutto, V ^e   Segura, D ^e   Senise, M ^e   Valesani, G ^e   Villa, A ^e   Zuin, D ^e   Chaves, G ^e   Garraghan, A ^e   Fiorentini, L ^e   Ramirez M ^e,e   Tuminello, G ^e   Roumec, B ^e   Orona, G ^e   Aschero, I ^e   Rodriguez M ^e   Ussher, C ^e   Lemme, L ^e   Stein, G ^e   Milanesio, J ^e   Almeida, A ^e   Ortiz, C ^e   more..

^a INEBA Neurosciences Institute of Buenos Aires ^*  (Argentina)

^b UNIVERSITY AT BUFFALO   (United States)

^c JACOBS NEUROLOGICAL INSTITUTE   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e Neurosciences Institute of Buenos Aires ^*

Author keywords

Cognition; Multiple sclerosis; Neuropsychology; Screening

Indexed keywords

ADULT; ARGENTINA; ARTICLE; BECK DEPRESSION INVENTORY; COGNITIVE DEFECT; CONTROLLED STUDY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS NEUROPSYCHOLOGICAL SCREENING QUESTIONNAIRE; NEUROPSYCHOLOGICAL TEST; RELIABILITY; RISK ASSESSMENT; SELF REPORT; SENSITIVITY AND SPECIFICITY; TEST RETEST RELIABILITY; VALIDATION PROCESS; VALIDITY;

ADULT; ARGENTINA; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 59349105878     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508097924     Document Type: Article

References (41)

1. Rao SM Leo GJ Bernardin L Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991; 41: 685-691.
2. Benedict RHB Cookfair D Gavett R. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12: 549-558.
3. Caceres F Vanotti S Gold B Rao S Grupo de Trabajo RECONEM. The RECONEM Study: Cognitive impairment in multiple sclerosis, a national survey in Argentina. Neurology 2003; 60: A54.
4. Rao SM Leo GJ Ellington L Nauertz T Bernardin L Unveragt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41: 692-696.
5. Benedict RHB Wahlig E Bakshi R. Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005; 231(1-2): 29-34.
6. Miller DM Rudick RA Baier M. Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler 2003; 9: 1-5.
7. Benedict RHB Munschauer F Zarevics P. Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients. J Neurol 2007; 13(2): 272-274.
8. Krupp LB Christodoulou C Melville P Scherl WF MacAllister WS Elkins LE. Donepezil improves memory in multiple sclerosis in a randomized clinical trial. Neurology 2004; 63: 1579-1585.
9. Bobholz JA Rao SM. Cognitive dysfunction in multiple sclerosis: A review of recent developments. Curr Opin Neurol 2003; 16: 283-288.
10. Rao SM. Neuropsychological Screening Battery for Multiple Sclerosis. Unpublished Manuscript, Section of Neuropsychology, Department of Neurology, Medical College of Wisconsin, 1991.
11. Beatty WW Paul RH Wilbanks SL Hames KA Blanco CR Goodkin DE. Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI). Neurology 1995; 45: 718-723.
12. Parmenter BA Weinstock-Guttman B Garg N Munschauer F Benedict RHB. Screening for cognitive impairment in MS using the Symbol Digit Modalities Test. Mult Scler 2006; 13(2): 272-274.
13. Benedict RHB Cox D Thompson LL Foley FW Weinstock-Guttman B Munschauer F. Reliable screening for neuropsychological impairment in MS. Mult Scler 2004; 10: 675-678.
14. Benedict RHB Zivadinov R. Predicting neuropsychological abnormalities in multiple sclerosis. J Neurol Sci 2006; 245: 67-72.
15. Carone D Benedict RHB Munschauer FE Fishman I Weinstock-Guttman B. Interpreting patient/informant discrepancies of reported cognitive symptoms in MS. J Int Neuropsychol Soc 2005; 11: 574-583.
16. Benedict RHB Munschauer FE Linn R Miller C Foley FW Jacobs LD. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler 2003; 9: 95-101.
17. O'Brien A Gaudino-Goering E Shawaryn M Komaroff E Moore NB DeLuca J. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes. Arch Clin Neuropsychol 2007; 22: 933-948.
18. Polman CH Reingold SC Edan G. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846.
19. Lublin FD Reingold SC Lublin FD Reingold SC. [see comment] Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911.
20. Sepulcre J Vanotti S Hernandez R Sandoval G Caceres F Garcea O. Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test. Mult Scler 2006; 12: 187-195.
21. Folstein MF Folstein S McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
22. Rao SM. A manual for the brief, repeatable battery of neuropsychological tests in multiple sclerosis. Unpublished Manuscript, Section of Neuropsychology, Department of Neurology, Medical College of Wisconsin, 1991.
23. Buschke F Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974; 24: 1019-1025.
24. Barbizet J Cany E. Coinical and psychometric study of a paitent with memory disturbances. Int J Neurol 1968; 7: 44-54.
25. Gronwall DMA. Paced auditory serial addition task: A measure of recovery from concussion. Percept Mot Skills 1977; 44: 367-373.
26. Smith A. Symbol digit modalities test: Manual. Los Angeles: Western Psychological Services; 1982.
27. Fischer JS Rudick RA Cutter GR Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): An integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5: 244-250.
28. Cutter GR Baier ML Rudick RA. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122: 871-882.
29. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Ann Neurol 1983; 13: 227-231.
30. Beck AT Steer RA Brown GK. BDI-Fast Screen for medical patients: Manual. San Antonio, TX: Psychological Corporation; 2000.
31. Benedict RHB Fishman I McClellan MM Bakshi R Weinstock-Guttman B. Validity of the Beck Depression Inventory - Fast Screen in multiple sclerosis. Mult Scler 2003; 9: 393-396.
32. Benedict RHB. Force NCaMT. Assessment and management of cognitive impairment in multiple sclerosis. In: NM Society, ed. New York, NY; 2006.
33. Benedict RHB Fischer JS Archibald CJ. Minimal neuropsychological assessment of MS patients: A consensus approach. Clin Neuropsychol 2002; 16: 381-397.
34. Benedict RHB Duquin JA Jurgensen S. Repeated assessment of neuropsychological deficits in multiple sclerosis using the symbol digit modalities test and the MS neuropsychological screening questionnaire. Mult Scler 14(7): 740-746.
35. Deloire MS Bonnet MC Salort E. How to detect cognitive dysfunction at early stages of multiple sclerosis. Mult Scler 2006; 12: 445-452.
36. Benedict RHB. Effects of using same vs alternate form memory tests during short-interval repeated assessments in multiple sclerosis. J Int Neuropsychol Soc 2005; 11(6): 727-736.
37. Christodoulou C Krupp LB Liang Z. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 2003; 60: 1793-1798.
38. Tekok-Kilic A Benedict RHB Weinstock-Guttman B. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. NeuroImage 2007; 36: 1294-1300.
39. Houtchens MK Benedict RHB Killiany R. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007; 67(12): 1213-1223.
40. Benedict RHB Bruce JM Dwyer MG. Neocortical atrophy, third ventricular width, and cognitive dysfunciton in multiple sclerosis. Arch Neurol 2006; 63: 1301-1306.
41. Benedict RHB Weinstock-Guttman B Fishman I Sharma J Tjoa CW Bakshi R. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004; 61: 226-230.